Covid vaccine: Pfizer says it's '94% effective in over-65s'
The coronavirus vaccine developed by Pfizer and BioNTech appears to protect 94% of adults over 65 years old.
More data released from their ongoing phase three trial suggests it works equally well in people of all ages and ethnicities.
The companies say they will now apply for authorisation for emergency use of the jab in the US.
The findings are based on two doses given to more than 41,000 people around the world.
Iran admits breach of nuclear deal discovered by UN inspectorate
Iran uses advanced uranium-enriching centrifuges in underground plant in breach of 2015 nuclear agreement
No comments:
Post a Comment